Loading...
Please wait, while we are loading the content...
Similar Documents
Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Boer, H. H. Hans De Verschoor, Louis Ruinemans-Koerts, Janneke Jansen, Melanie |
| Copyright Year | 2005 |
| Abstract | BACKGROUND Morbid obesity is associated with increased estradiol production as a result of aromatase-dependent conversion of testosterone to estradiol. The elevated serum estradiol levels may inhibit pituitary LH secretion to such extent that hypogonadotropic hypogonadism can result. Normalization of the disturbed estradiol-testosterone balance may be beneficial to reverse the adverse effects of hypogonadism. AIM To examine whether aromatase inhibition with Letrozole can normalize serum testosterone levels in severely obese men with hypogonadotropic hypogonadism. PATIENTS AND METHODS Ten severely obese men, mean age 48.2 +/- 2.3 (s.e.) years and body mass index 42.1 +/- 2.6 kg/m(2), were treated with Letrozole for 6 weeks in doses ranging from 7.5 to 17.5 mg per week. RESULTS Six weeks of treatment decreased serum estradiol from 120 +/- 20 to 70 +/- 9 pmol/l (p = 0.006). None of the subjects developed an estradiol level of less than 40 pmol/l. LH increased from 4.5 +/- 0.8 to 14.8 +/- 2.3 U/l (p < 0.001). Total testosterone rose from 7.5 +/- 1.0 to 23.8 +/- 3.0 nmol/l (p < 0.001) without a concomitant change in sex hormone-binding globulin level. Those treated with Letrozole 17.5 mg per week had an excessive LH response. CONCLUSION Short-term Letrozole treatment normalized serum testosterone levels in all obese men. The clinical significance of this intervention remains to be established in controlled, long-term studies. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.hormonebalance.org/images/documents/de%20Boer%2005%20femara%20obese%20men%20O&M.pdf |
| PubMed reference number | 15811136v1 |
| Volume Number | 7 |
| Issue Number | 3 |
| Journal | Diabetes, obesity & metabolism |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Body mass index CYP19A1 gene Estradiol Globulins Gonadal Steroid Hormones Hypogonadism Klinefelter Syndrome Nanomole/liter Obesity Hypoventilation Syndrome Patients Picomole per Liter Sex Factors Testosterone aromatase inhibition letrozole |
| Content Type | Text |
| Resource Type | Article |
